News Focus
News Focus
icon url

Zadie420

01/23/25 9:02 AM

#744980 RE: flipper44 #744979

Yep. But big BPs have a bigger hole in their pocket. Also, I think NWBO have a lot of iron in the fire. That is the reason they are focusing to bring EDEN into commercialization.
icon url

dennisdave

01/23/25 11:18 AM

#745044 RE: flipper44 #744979

There are also mid to smaller companies making ctla ci’s, such as biontech.

True but only Bristol Myers Squibb (BMS) and AstraZeneca produce FDA-approved CTLA-4 Blockade in Tumor. I find it highly unlikely that NWBO would pursue combi trials with UNapproved CTLA-4 while DCVAXL is MHRA approved